A detailed history of Squarepoint Ops LLC transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 4,525 shares of KROS stock, worth $75,612. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,525
Previous 19,832 77.18%
Holding current value
$75,612
Previous $906,000 71.08%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$41.68 - $58.07 $637,995 - $888,877
-15,307 Reduced 77.18%
4,525 $262,000
Q2 2024

Aug 14, 2024

BUY
$44.58 - $66.89 $884,110 - $1.33 Million
19,832 New
19,832 $906,000
Q3 2022

Nov 14, 2022

BUY
$27.8 - $40.12 $61,271 - $88,424
2,204 Added 12.44%
19,919 $749,000
Q2 2022

Aug 15, 2022

BUY
$26.03 - $67.04 $461,121 - $1.19 Million
17,715 New
17,715 $489,000
Q1 2021

May 17, 2021

SELL
$54.0 - $75.28 $487,890 - $680,154
-9,035 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$36.0 - $82.74 $325,260 - $747,555
9,035 New
9,035 $637,000

Others Institutions Holding KROS

About Keros Therapeutics, Inc.


  • Ticker KROS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,757,000
  • Market Cap $430M
  • Description
  • Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...
More about KROS
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.